Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency.

Martos L, Fernández-Pardo Á, López-Fernández MF, Ibáñez F, Herrero S, Tàssies D, González-Porras JR, Solmoirago MJ, Costa MJ, Reverter JC, Marco P, Roldán V, Lecumberri R, Velasco F, Oto J, Iruin G, Alonso MN, Vayá A, Bonanad S, Ferrando F, Martí E, Cid AR, Plana E, Oña F, Cuesta I, González-López TJ, España F, Medina P, Navarro S; Working Group of the Spanish Society of Thrombosis Haemostasis (SETH).

Thromb Haemost. 2019 Sep;119(9):1409-1418. doi: 10.1055/s-0039-1692440. Epub 2019 Jun 29.

PMID:
31254973
2.

α2-Macroglobulin Is a Significant In Vivo Inhibitor of Activated Protein C and Low APC:α2M Levels Are Associated with Venous Thromboembolism.

Martos L, Ramón LA, Oto J, Fernández-Pardo Á, Bonanad S, Cid AR, Gruber A, Griffin JH, España F, Navarro S, Medina P.

Thromb Haemost. 2018 Apr;118(4):630-638. doi: 10.1055/s-0038-1629902. Epub 2018 Feb 15.

3.

Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases.

Deguchi H, Navarro S, Payne AB, Elias DJ, Dowling NF, Austin HD, España F, Medina P, Hooper WC, Griffin JH.

Res Pract Thromb Haemost. 2017 Jul;1(1):33-40. doi: 10.1002/rth2.12018. Epub 2017 Jun 23.

4.

Spanish Consensus Statement: Clinical Management and Treatment of Tendinopathies in Sport.

Spanish Group for Tendon Consensus, Fernandez-Jaén T, Rey GÁ, Angulo F, Cuesta JA, Loureda RA, España FÁ, Ayala J, Matas RB, Pazos FB, de Dios Beas Jiménez J, Rosell JC, Fernandez CC, Del Pilar Doñoro Cuevas M, Ros FE, Colmenero JE, de Prado JF, García Cota JJ, Garrido González JI, de Vega CG, Santander MG, Herrador Munilla MÁ, Ruiz FI, Díaz FJ, Fernandez AM, Marqueta PM, Muñoz Benito JJ, Vilás RO, Pedret C, Teres XP, Amaro JP, Grifell JP, San Roque JP, Parenteu CR, Serna JR, Rodas G, Álvarez MS, Marchori CS, Perez LT, Durán RU, Del Valle Soto M, Villalón Alonso JM, García PG.

Orthop J Sports Med. 2017 Oct 31;5(10):2325967117734127. doi: 10.1177/2325967117734127. eCollection 2017 Oct.

5.

Comparison of protocols and RNA carriers for plasma miRNA isolation. Unraveling RNA carrier influence on miRNA isolation.

Ramón-Núñez LA, Martos L, Fernández-Pardo Á, Oto J, Medina P, España F, Navarro S.

PLoS One. 2017 Oct 27;12(10):e0187005. doi: 10.1371/journal.pone.0187005. eCollection 2017.

6.

A simplified assay for the quantification of circulating activated protein C.

Martos L, Bonanad S, Ramón LA, Cid AR, Bonet E, Corral J, Miralles M, España F, Navarro S, Medina P.

Clin Chim Acta. 2016 Aug 1;459:101-104. doi: 10.1016/j.cca.2016.05.025. Epub 2016 Jun 2.

PMID:
27262823
7.

Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect.

de la Morena-Barrio ME, Martínez-Martínez I, de Cos C, Wypasek E, Roldán V, Undas A, van Scherpenzeel M, Lefeber DJ, Toderici M, Sevivas T, España F, Jaeken J, Corral J, Vicente V.

J Thromb Haemost. 2016 Aug;14(8):1549-60. doi: 10.1111/jth.13372. Epub 2016 Jun 29.

8.

Spanish Consensus Statement: The Treatment of Muscle Tears in Sport.

Fernandez-Jaén TF, Rey GÁ, Cuesta JA, Loureda RA, España FÁ, Matas RB, Pazos FB, de Dios Beas Jiménez J, Rosell JC, Fernandez CC, Ros FE, Colmenero JE, de Prado JF, Cota JJ, González JI, Santander MG, Munilla MÁ, Ruiz FI, Díaz FJ, Marqueta PM, Fernandez AM, Benito JJ, Vilás RO, Teres XP, Amaro JP, Roque JP, Parenteu CR, Serna JR, Álvarez MS, Marchori CS, Soto Mdel V, Alonso JM, García PG, de la Iglesia NH, Alcorocho JM.

Orthop J Sports Med. 2016 Feb 4;3(12):2325967115622434. doi: 10.1177/2325967115622434. eCollection 2015 Dec.

9.

Red blood cell distribution width in patients with cryptogenic stroke.

Vayá A, Hernández V, Rivera L, Hernández JL, Lago A, España F, Bautista D.

Clin Appl Thromb Hemost. 2015 Apr;21(3):241-5. doi: 10.1177/1076029614547262. Epub 2014 Aug 25.

PMID:
25155500
10.

MicroRNA expression profile in endometriosis: its relation to angiogenesis and fibrinolytic factors.

Braza-Boïls A, Marí-Alexandre J, Gilabert J, Sánchez-Izquierdo D, España F, Estellés A, Gilabert-Estellés J.

Hum Reprod. 2014 May;29(5):978-88. doi: 10.1093/humrep/deu019. Epub 2014 Mar 6.

PMID:
24608518
11.

Functional analysis of two haplotypes of the human endothelial protein C receptor gene.

Medina P, Navarro S, Bonet E, Martos L, Estellés A, Bertina RM, Vos HL, España F.

Arterioscler Thromb Vasc Biol. 2014 Mar;34(3):684-90. doi: 10.1161/ATVBAHA.113.302518. Epub 2014 Jan 16.

PMID:
24436369
12.

Differential gene expression of cardiac ion channels in human dilated cardiomyopathy.

Molina-Navarro MM, Roselló-Lletí E, Ortega A, Tarazón E, Otero M, Martínez-Dolz L, Lago F, González-Juanatey JR, España F, García-Pavía P, Montero JA, Portolés M, Rivera M.

PLoS One. 2013 Dec 5;8(12):e79792. doi: 10.1371/journal.pone.0079792. eCollection 2013.

13.

Characterization of variants in the glucosylceramide synthase gene and their association with type 1 Gaucher disease severity.

Alfonso P, Navascués J, Navarro S, Medina P, Bolado-Carrancio A, Andreu V, Irún P, Rodríguez-Rey JC, Pocoví M, España F, Giraldo P.

Hum Mutat. 2013 Oct;34(10):1396-403. doi: 10.1002/humu.22381. Epub 2013 Aug 13.

PMID:
23913449
14.

Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method.

Cabrera N, Moret A, Caunedo P, Cid AR, Vila V, España F, Aznar JA.

Haemophilia. 2013 Nov;19(6):920-5. doi: 10.1111/hae.12203. Epub 2013 Jun 4.

PMID:
23730809
15.

Peritoneal fluid reduces angiogenesis-related microRNA expression in cell cultures of endometrial and endometriotic tissues from women with endometriosis.

Braza-Boïls A, Gilabert-Estellés J, Ramón LA, Gilabert J, Marí-Alexandre J, Chirivella M, España F, Estellés A.

PLoS One. 2013 Apr 19;8(4):e62370. doi: 10.1371/journal.pone.0062370. Print 2013.

16.

Association of the thrombomodulin gene c.1418C>T polymorphism with thrombomodulin levels and with venous thrombosis risk.

Navarro S, Medina P, Bonet E, Corral J, Martínez-Sales V, Martos L, Rivera M, Roselló-Lletí E, Alberca I, Roldán V, Mira Y, Ferrando F, Estellés A, Vicente V, Bertina RM, España F.

Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1435-40. doi: 10.1161/ATVBAHA.113.301360. Epub 2013 Mar 21.

PMID:
23520161
17.

Elevated serum amyloid A is associated with venous thromboembolism.

Deguchi H, Elias DJ, Navarro S, España F, Griffin JH.

Thromb Haemost. 2013 Feb;109(2):358-9. doi: 10.1160/TH12-10-0722. Epub 2012 Dec 20. No abstract available.

18.

Assessment of the thrombin generation assay in haemophilia: comparative study between fresh and frozen platelet-rich plasma.

Vila V, Aznar JA, Moret A, Marco A, Navarro S, Vila C, España F.

Haemophilia. 2013 Mar;19(2):318-21. doi: 10.1111/hae.12044. Epub 2012 Nov 23.

PMID:
23174035
19.

Heart failure induces significant changes in nuclear pore complex of human cardiomyocytes.

Tarazón E, Rivera M, Roselló-Lletí E, Molina-Navarro MM, Sánchez-Lázaro IJ, España F, Montero JA, Lago F, González-Juanatey JR, Portolés M.

PLoS One. 2012;7(11):e48957. doi: 10.1371/journal.pone.0048957. Epub 2012 Nov 12.

20.

microRNAs related to angiogenesis are dysregulated in endometrioid endometrial cancer.

Ramón LA, Braza-Boïls A, Gilabert J, Chirivella M, España F, Estellés A, Gilabert-Estellés J.

Hum Reprod. 2012 Oct;27(10):3036-45. doi: 10.1093/humrep/des292. Epub 2012 Aug 17.

PMID:
22904162
21.

Mean platelet volume does not seem to relate to thrombosis or posterior uveitis in Behçet's disease.

Ricart JM, España F, Navarro S, Todolí J, Miguel De la Fuente J, Vayá A.

Clin Hemorheol Microcirc. 2013 Jan 1;54(1):51-7. doi: 10.3233/CH-2012-1564.

PMID:
22750994
22.

Role of microRNAs in gynecological pathology.

Gilabert-Estelles J, Braza-Boils A, Ramon LA, Zorio E, Medina P, Espana F, Estelles A.

Curr Med Chem. 2012;19(15):2406-13. Review.

PMID:
22455593
23.

Effects of oral anticoagulant therapy and haplotype 1 of the endothelial protein C receptor gene on activated protein C levels.

Medina P, Bonet E, Navarro S, Martos L, Estellés A, Ferrando F, Vicente V, Bertina RM, España F.

Thromb Haemost. 2012 Mar;107(3):448-57. doi: 10.1160/TH11-07-0510. Epub 2012 Jan 25.

PMID:
22273845
24.

Plasminogen activator inhibitor-1 (PAI-1) 4 G/5 G polymorphism and endometrial cancer. Influence of PAI-1 polymorphism on tissue PAI-1 antigen and mRNA expression and tumor severity.

Gilabert-Estellés J, Ramón LA, Braza-Boïls A, Gilabert J, Chirivella M, España F, Estellés A.

Thromb Res. 2012 Aug;130(2):242-7. doi: 10.1016/j.thromres.2011.10.007. Epub 2011 Nov 4.

PMID:
22055623
25.

The endothelial cell protein C receptor: its role in thrombosis.

Navarro S, Bonet E, Estellés A, Montes R, Hermida J, Martos L, España F, Medina P.

Thromb Res. 2011 Nov;128(5):410-6. doi: 10.1016/j.thromres.2011.08.001. Epub 2011 Sep 7. Review.

PMID:
21903242
26.

Haplotypes of the endothelial protein C receptor gene and Behçet's disease.

Navarro S, Bonet E, Medina P, Martos L, Ricart JM, Vayá A, Todolí J, Fontcuberta J, Estellés A, España F.

Thromb Res. 2012 Apr;129(4):459-64. doi: 10.1016/j.thromres.2011.07.032. Epub 2011 Aug 17.

PMID:
21851971
27.

Limited ability to activate protein C confers left atrial endocardium a thrombogenic phenotype: a role in cardioembolic stroke?

Cerveró J, Montes R, España F, Esmon CT, Hermida J.

Stroke. 2011 Sep;42(9):2622-4. doi: 10.1161/STROKEAHA.111.614420. Epub 2011 Jun 23.

28.

[Treatment of refractory hepatic encephalopathy associated with insertion of a transjugular intrahepatic portosystemic shunt through new endovascular techniques: a case report].

Martínez Moreno B, Bellot P, de España F, Palazón JM, Such J, Pérez-Mateo M.

Gastroenterol Hepatol. 2011 Aug-Sep;34(7):468-73. doi: 10.1016/j.gastrohep.2011.03.021. Epub 2011 Jun 8. Spanish.

PMID:
21652116
29.

The metabolic syndrome and its individual components: its association with venous thromboembolism in a Mediterranean population.

Vayá A, Martínez-Triguero ML, España F, Todolí JA, Bonet E, Corella D.

Metab Syndr Relat Disord. 2011 Jun;9(3):197-201. doi: 10.1089/met.2010.0117. Epub 2011 Feb 25.

PMID:
21352080
30.

microRNAs expression in endometriosis and their relation to angiogenic factors.

Ramón LA, Braza-Boïls A, Gilabert-Estellés J, Gilabert J, España F, Chirivella M, Estellés A.

Hum Reprod. 2011 May;26(5):1082-90. doi: 10.1093/humrep/der025. Epub 2011 Feb 18.

PMID:
21335415
31.

Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm.

Gretarsdottir S, Baas AF, Thorleifsson G, Holm H, den Heijer M, de Vries JP, Kranendonk SE, Zeebregts CJ, van Sterkenburg SM, Geelkerken RH, van Rij AM, Williams MJ, Boll AP, Kostic JP, Jonasdottir A, Jonasdottir A, Walters GB, Masson G, Sulem P, Saemundsdottir J, Mouy M, Magnusson KP, Tromp G, Elmore JR, Sakalihasan N, Limet R, Defraigne JO, Ferrell RE, Ronkainen A, Ruigrok YM, Wijmenga C, Grobbee DE, Shah SH, Granger CB, Quyyumi AA, Vaccarino V, Patel RS, Zafari AM, Levey AI, Austin H, Girelli D, Pignatti PF, Olivieri O, Martinelli N, Malerba G, Trabetti E, Becker LC, Becker DM, Reilly MP, Rader DJ, Mueller T, Dieplinger B, Haltmayer M, Urbonavicius S, Lindblad B, Gottsäter A, Gaetani E, Pola R, Wells P, Rodger M, Forgie M, Langlois N, Corral J, Vicente V, Fontcuberta J, España F, Grarup N, Jørgensen T, Witte DR, Hansen T, Pedersen O, Aben KK, de Graaf J, Holewijn S, Folkersen L, Franco-Cereceda A, Eriksson P, Collier DA, Stefansson H, Steinthorsdottir V, Rafnar T, Valdimarsson EM, Magnadottir HB, Sveinbjornsdottir S, Olafsson I, Magnusson MK, Palmason R, Haraldsdottir V, Andersen K, Onundarson PT, Thorgeirsson G, Kiemeney LA, Powell JT, Carey DJ, Kuivaniemi H, Lindholt JS, Jones GT, Kong A, Blankensteijn JD, Matthiasson SE, Thorsteinsdottir U, Stefansson K.

Nat Genet. 2010 Aug;42(8):692-7. doi: 10.1038/ng.622. Epub 2010 Jul 11.

32.

Acute and chronic hemodynamic changes after propranolol in patients with cirrhosis under primary and secondary prophylaxis of variceal bleeding: a pilot study.

de-Madaria E, Palazón JM, Hernández FT, Sánchez-Paya J, Zapater P, Irurzun J, de España F, Pascual S, Such J, Sempere L, Carnicer F, García-Herola A, Valverde J, Pérez-Mateo M.

Eur J Gastroenterol Hepatol. 2010 May;22(5):507-12. doi: 10.1097/MEG.0b013e32832ca06b.

PMID:
20150817
33.

Pathophysiology of the proatherothrombotic state in the metabolic syndrome.

Palomo I, Moore-Carrasco R, Alarcon M, Rojas A, Espana F, Andres V, Gonzalez-Navarro H.

Front Biosci (Schol Ed). 2010 Jan 1;2:194-208. Review.

34.

Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis.

Cosín R, Gilabert-Estellés J, Ramón LA, Gómez-Lechón MJ, Gilabert J, Chirivella M, Braza-Boïls A, España F, Estellés A.

Hum Reprod. 2010 Feb;25(2):398-405. doi: 10.1093/humrep/dep419. Epub 2009 Nov 26.

PMID:
19945964
35.

Influence of porosity on mechanical properties and in vivo response of Ti6Al4V implants.

Bandyopadhyay A, Espana F, Balla VK, Bose S, Ohgami Y, Davies NM.

Acta Biomater. 2010 Apr;6(4):1640-8. doi: 10.1016/j.actbio.2009.11.011. Epub 2009 Nov 12.

36.

Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis.

Roldán V, Ordoñez A, Marín F, Zorio E, Soria JM, Miñano A, España F, González-Conejero R, Pineda J, Estellés A, Fontcuberta J, Vicente V, Corral J.

Thromb Haemost. 2009 Mar;101(3):483-6.

PMID:
19277409
37.

Insights into the role of microRNAs in cardiac diseases: from biological signalling to therapeutic targets.

Zorio E, Medina P, Rueda J, Millán JM, Arnau MA, Beneyto M, Marín F, Gimeno JR, Osca J, Salvador A, España F, Estellés A.

Cardiovasc Hematol Agents Med Chem. 2009 Jan;7(1):82-90. Review.

PMID:
19149547
38.

Heritability of plasma concentrations of activated protein C in a Spanish population.

Soria JM, Navarro S, Medina P, Souto R, Buil A, Estellés A, Fontcuberta J, España F.

Blood Coagul Fibrinolysis. 2009 Jan;20(1):17-21. doi: 10.1097/MBC.0b013e3282f9ae25.

PMID:
19129726
39.

Obesity and activated protein C resistance.

Solá E, Vayá A, Villa P, España F, Estellés A, García K, Hernández-Mijares A.

Pathophysiol Haemost Thromb. 2008;36(2):64-8. doi: 10.1159/000173723. Epub 2009 Jan 5.

PMID:
19127084
40.

Erythrocyte membrane phosphatidylserine exposure in obesity.

Solá E, Vayá A, Martínez M, Moscardó A, Corella D, Santaolaria ML, España F, Hernández-Mijares A.

Obesity (Silver Spring). 2009 Feb;17(2):318-22. doi: 10.1038/oby.2008.499. Epub 2008 Nov 20.

41.

Vascular endothelial growth factor polymorphisms (-460C/T, +405G/C, and 936C/T) and endometriosis: their influence on vascular endothelial growth factor expression.

Cosín R, Gilabert-Estellés J, Ramón LA, España F, Gilabert J, Romeu A, Estellés A.

Fertil Steril. 2009 Oct;92(4):1214-20. doi: 10.1016/j.fertnstert.2008.08.079. Epub 2008 Oct 18.

PMID:
18930211
42.

Activated protein C levels in obesity and weight loss influence.

Solá E, Navarro S, Medina P, Vayá A, Estellés A, Hernández-Mijares A, España F.

Thromb Res. 2009 Mar;123(5):697-700. doi: 10.1016/j.thromres.2008.07.017. Epub 2008 Oct 2.

PMID:
18834618
43.

Endothelial protein C receptor polymorphisms and risk of myocardial infarction.

Medina P, Navarro S, Corral J, Zorio E, Roldán V, Estellés A, Santamaría A, Marín F, Rueda J, Bertina RM, España F; RECAVA Thrombosis Groups.

Haematologica. 2008 Sep;93(9):1358-63. doi: 10.3324/haematol.13066.

44.

The -589C>T polymorphism in the interleukin-4 gene (IL-4) is associated with a reduced risk of myocardial infarction in young individuals.

Paffen E, Medina P, de Visser MC, van Wijngaarden A, Zorio E, Estellés A, Rosendaal FR, España F, Bertina RM, Doggen CJ.

J Thromb Haemost. 2008 Oct;6(10):1633-8. doi: 10.1111/j.1538-7836.2008.03096.x. Epub 2008 Jul 25.

45.

Successful endovascular treatment of a large idiopathic azygos arch aneurysm.

Irurzun J, de España F, Arenas J, García-Sevila R, Gil S.

J Vasc Interv Radiol. 2008 Aug;19(8):1251-4. doi: 10.1016/j.jvir.2008.04.011. Epub 2008 May 22.

PMID:
18656023
46.

Fibrinolysis: the key to new pathogenetic mechanisms.

Zorio E, Gilabert-Estellés J, España F, Ramón LA, Cosín R, Estellés A.

Curr Med Chem. 2008;15(9):923-9. Review.

PMID:
18473800
47.

Usefulness of surveillance programmes for early diagnosis of hepatocellular carcinoma in clinical practice.

Pascual S, Irurzun J, Zapater P, Such J, Sempere L, Carnicer F, Palazón JM, de la Iglesia P, Gil S, de España F, Perez-Mateo M.

Liver Int. 2008 May;28(5):682-9. doi: 10.1111/j.1478-3231.2008.01710.x.

PMID:
18433394
48.

Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression.

Ramón LA, Gilabert-Estellés J, Cosín R, Gilabert J, España F, Castelló R, Chirivella M, Romeu A, Estellés A.

Thromb Res. 2008;122(6):854-60. doi: 10.1016/j.thromres.2008.02.010. Epub 2008 Apr 18.

PMID:
18423526
49.

Haplotypes of the EPCR gene, prothrombin levels, and the risk of venous thrombosis in carriers of the prothrombin G20210A mutation.

Navarro S, Medina P, Mira Y, Estellés A, Villa P, Ferrando F, Vayá A, Bertina RM, España F.

Haematologica. 2008 Jun;93(6):885-91. doi: 10.3324/haematol.12448. Epub 2008 Apr 9.

50.

AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.

Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, Llamas P, Marín F, Estellés A, Alberca I, Vicente V, Corral J.

Haematologica. 2008 May;93(5):729-34. doi: 10.3324/haematol.12271. Epub 2008 Apr 2.

Supplemental Content

Loading ...
Support Center